Therapeutic Applications of Fatty Acid Amide Hydrolase Inhibitors
Fatty acid amide hydrolase (FAAH) is an enzyme responsible for the degradation of oleamide (an endogenous sleep-inducing lipid) and anandamide (an endogenous ligand for cannabinoid receptors). Disclosed herein are potent inhibitors of FAAH and methods for their use for treating a variety of disorder, including hypertension and cardiac hypertrophy.
Patents:WO 2,009,051,666
Inventor(s):
KUNOS GEORGE [US]; MAKRIYANNIS ALEXANDROS [US]
Type of Offer:
Licensing
« More Medical Patents